Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2020
ICER posts draft scoping document on lupus nephritis
31 August 2020 - Document open to public comment until 21 September 2020. ...
Posted by Michael Wonder on 31 Aug 2020
ICER to assess CAR-T cell therapies for multiple myeloma
31 August 2020 - Report will be subject of Midwest CEPAC meeting in April 2021; open input now being accepted until ...
Posted by Michael Wonder on 26 Aug 2020
ICER releases draft evidence report on therapies for haemophilia A
26 August 2020 - Public comment period now open until 23 September 2020; requests to make oral comment during public meeting ...
Posted by Michael Wonder on 15 Aug 2020
Many psoriasis patients are paying higher prices than ever at the pharmacy counter
13 August 2020 - Over the past decade, wholesale prices for self-administered psoriasis medicines rose substantially, underscoring the ongoing financial ...
Posted by Michael Wonder on 10 Aug 2020
Coming of age: emerging health preference research based on established scientific standards
10 August 2020 - Value in Health themed section enhances the scientific respectability and relevance of health preference research. ...
Posted by Michael Wonder on 10 Aug 2020
ICER to assess treatments for lupus nephritis
10 August 2020 - Report will be subject of New England CEPAC meeting in March 2021; Open Input now being accepted ...
Posted by Michael Wonder on 06 Aug 2020
Principles for deliberative processes in health technology assessment
4 August 2020 - Deliberative processes are a well-established part of health technology assessment programs in a number of high- and ...
Posted by Michael Wonder on 22 Jul 2020
COVID-19 and ISPOR conferences
22 July 2020 - ISPOR redesigns remaining conferences for 2020. ...
Posted by Michael Wonder on 21 Jul 2020
ICER publishes evidence report on obeticholic acid for the treatment of non-alcoholic steatohepatitis
21 July 2020 - Given the FDA’s recent decision to not grant accelerated approval for the treatment, ICER has canceled its ...
Posted by Michael Wonder on 20 Jul 2020
ICER posts draft scoping document for the assessment of anaemia in chronic kidney disease treatments
20 July 2020 - Document open to public comment until 7 August 2020 ...
Posted by Michael Wonder on 08 Jul 2020
ICER reschedules cystic fibrosis public meeting for 27 August 2020
8 July 2020 - Registration is now open. ...
Posted by Michael Wonder on 06 Jul 2020
ICER posts draft scoping document on high cholesterol
6 July 2020 - Document open to public comment until 24 July 2020. ...
Posted by Michael Wonder on 05 Jul 2020
Beyond the numbers: a critique of quantitative multi-criteria decision analysis
1 July 2020 - When setting priorities for health, there is broad agreement that a range of social values and ethical ...
Posted by Michael Wonder on 02 Jul 2020
ICER publishes white paper on alternative policies for drug and vaccine pricing during a pandemic, announces cross-stakeholder discussion series
2 July 2020 - The Institute for Clinical and Economic Review today published a white paper to inform public and policy ...
Posted by Michael Wonder on 01 Jul 2020
ICER cancels public meeting for non-alcoholic steatohepatitis assessment
1 July 2020 - August 2020 public meeting cancelled; evidence report being posted on 21 July 2020. ...